ISIS 1 Therapeutic Effectiveness
Primary Purpose
OSAS (Obstructive Sleep Apneas Syndrome)
Status
Unknown status
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
titration night
Sponsored by
About this trial
This is an interventional treatment trial for OSAS (Obstructive Sleep Apneas Syndrome)
Eligibility Criteria
Inclusion Criteria:
- patient male or female, aged 18 to 75 years
- weight > 30kg
- patient with a newly diagnosed OSAS, under treatment with CPAP
- patient in stable condition
- patient affiliated to a social security insurance
- having given its written informed consent to participate to the study
Exclusion Criteria:
- pneumothorax or pneumomediastin history
- massive epistaxis (current or previous)
- decompensated heart failure or hypotension
- pneumoencephal history, recent trauma or surgery sequel with cranio-nasopharyngeal fistula
- acute sinusitis history, middle ear infection or perforation of the tympanic membrane
- respiratory insufficiency or severe respiratory illness with the possibility of residual hypoxemia
- severe bullous emphysema or previously complicated pneumothorax
- severe claustrophobia
Sites / Locations
- Hospital Michalon, sleep disorders centerRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Experimental
Arm Label
A
B
C
D
Arm Description
Phase 1 : manual Phase 2 : automatic Descent rate pressure : slow
Phase 1 : manual Phase 2 : automatic Descent Rate Pressure : fast
Phase 1 : automatic Phase 2 : manual Descent rate pressure : slow
Phase 1 : automatic Phase 2 : manual Descent Rate Pressure : fast
Outcomes
Primary Outcome Measures
To determine the sensitivity and specificity of the CPAP/autoCPAP Sandman in adequately detecting respiratory events and to evaluate the therapeutic effectiveness of the device in improving sleep quality and normalizing respiratory events
Secondary Outcome Measures
To compare effective pressure Peff determined by the device and during manual titration
To compare the impact of the two-speed descent pressure algorithm
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00646477
Brief Title
ISIS 1 Therapeutic Effectiveness
Official Title
Therapeutic Efficacy Evaluation of the CPAP/autoCPAP Sandman in the Treatment of New Patients With Obstructive Sleep Apnoea Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
March 2008
Overall Recruitment Status
Unknown status
Study Start Date
October 2007 (undefined)
Primary Completion Date
May 2008 (Anticipated)
Study Completion Date
May 2008 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Tyco Healthcare Group
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study is a prospective field evaluation to assess the therapeutic value of the CPAP/autoCPAP Sandman in 24 new diagnosed Obstructive Sleep Apneic patients.
Precisely, the study was designed to :
evaluate the therapeutic efficacy of the CPAP/autoCPAP Sandman device in improving sleep quality and normalozing respiratory events
determine the sensitivity and specificity of the device in adequately detecting respiratroy events
compare effective pressure Peff determined by the device and during manual titration
compare the impact of the two-speed descent pressure algorithm
Detailed Description
During the study, each patient underwent one night of full polysomnography with two consecutives therapeutic sequences during the same night, after randomization of the passage order:
autotitrating pressure phase: sleep parameters and respiratory events vs results of the polysomnographic registration,
manual titration phase: concordance between events respiratory analyzed on the polysomnographic recordings and the events detected by the CPAP / auto-CPAP.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
OSAS (Obstructive Sleep Apneas Syndrome)
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Description
Phase 1 : manual Phase 2 : automatic Descent rate pressure : slow
Arm Title
B
Arm Type
Experimental
Arm Description
Phase 1 : manual Phase 2 : automatic Descent Rate Pressure : fast
Arm Title
C
Arm Type
Experimental
Arm Description
Phase 1 : automatic Phase 2 : manual Descent rate pressure : slow
Arm Title
D
Arm Type
Experimental
Arm Description
Phase 1 : automatic Phase 2 : manual Descent Rate Pressure : fast
Intervention Type
Device
Intervention Name(s)
titration night
Intervention Description
Each subject undergo 1 night of full polysomnography split into 2 consecutives and randomized sequences, using the Sandman device into two different modes:
in APAP mode - Data analysis of this sequence will be used to evaluate the therapeutic effectiveness of the CPAP/autoCPAP Sandman in APAP mode compared both to the polysomnography registration and the diagnosis night for each enrolled patient. The type of respiratory events and their index/hour of sleep and the total arousal index will be appraised as markers of the efficacy of OSAS treatment, constituting the primary outcomes.
in CPAP mode for manual titration sequence.During the manual titration, 5 constant pressure levels settings were studied for equal periods of 30 minutes gradually increasing the pressure. The aim of this sequence is to determine the sensitivity and the specificity of the CPAP/autoCPAP Sandman in detecting respiratory events.
Primary Outcome Measure Information:
Title
To determine the sensitivity and specificity of the CPAP/autoCPAP Sandman in adequately detecting respiratory events and to evaluate the therapeutic effectiveness of the device in improving sleep quality and normalizing respiratory events
Time Frame
May 2008
Secondary Outcome Measure Information:
Title
To compare effective pressure Peff determined by the device and during manual titration
Time Frame
May 2008
Title
To compare the impact of the two-speed descent pressure algorithm
Time Frame
May 2008
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient male or female, aged 18 to 75 years
weight > 30kg
patient with a newly diagnosed OSAS, under treatment with CPAP
patient in stable condition
patient affiliated to a social security insurance
having given its written informed consent to participate to the study
Exclusion Criteria:
pneumothorax or pneumomediastin history
massive epistaxis (current or previous)
decompensated heart failure or hypotension
pneumoencephal history, recent trauma or surgery sequel with cranio-nasopharyngeal fistula
acute sinusitis history, middle ear infection or perforation of the tympanic membrane
respiratory insufficiency or severe respiratory illness with the possibility of residual hypoxemia
severe bullous emphysema or previously complicated pneumothorax
severe claustrophobia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Veronique Grillier-Lanoir
Organizational Affiliation
Tyco Healthcare Group
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital Michalon, sleep disorders center
City
Grenoble
ZIP/Postal Code
38049
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Louis PEPIN, Pr
Phone
+33 4 76 76 55 16
Email
JLPepin@chu-grenoble.fr
First Name & Middle Initial & Last Name & Degree
Patrick Levy, Pr
First Name & Middle Initial & Last Name & Degree
Jean-Louis Pepin, Pr
First Name & Middle Initial & Last Name & Degree
Renaud Tamisier, Dr
12. IPD Sharing Statement
Learn more about this trial
ISIS 1 Therapeutic Effectiveness
We'll reach out to this number within 24 hrs